Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions: Anemia; Renal Insufficiency, ChronicInterventions: Drug: Molidustat (BAY85-3934); Biological: Epoetin alfa/betaSponsor: BayerRecruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anemia | Chronic Kidney Disease | Dialysis | Epogen | Hemodialysis | Procrit | Research | Study | Urology & Nephrology